0001104659-20-022826.txt : 20200219 0001104659-20-022826.hdr.sgml : 20200219 20200219162304 ACCESSION NUMBER: 0001104659-20-022826 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200214 FILED AS OF DATE: 20200219 DATE AS OF CHANGE: 20200219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Hunter C CENTRAL INDEX KEY: 0001636385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38223 FILM NUMBER: 20630079 MAIL ADDRESS: STREET 1: C/O GENESEE & WYOMING INC. STREET 2: 20 WEST AVENUE CITY: DARIEN STATE: CT ZIP: 06820 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001649904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462159271 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-264-4280 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: RHYTHM METABOLIC, INC. DATE OF NAME CHANGE: 20150803 4 1 a4.xml 4 X0306 4 2020-02-14 0 0001649904 RHYTHM PHARMACEUTICALS, INC. RYTM 0001636385 Smith Hunter C 222 BERKELEY STREET, 12TH FLOOR BOSTON MA 02116 0 1 0 0 Chief Financial Officer Employee Stock Option (Right to Buy) 17.87 2020-02-14 4 A 0 82000 0 A 2030-02-13 Common Stock 82000 82000 D This option was granted on February 14, 2020 and the shares underlying this option vest in sixteen equal quarterly installments beginning on May 14, 2020. /s/ Hunter C. Smith 2020-02-19